Global Allergy Diagnostics Market Is Expected to Generate $16.7 Billion by 2031: Allied Market Research

Surge in respiratory diseases due to exposure to allergens, occupational exposure, and exposure to indoor and outdoor air pollution serves as a potential opportunity for the expansion of the global allergy diagnostics market. Based on region, North America held the largest share in 2021 and is projected to maintain its dominant share in terms of revenue in 2031.

Pune, INDIA


Portland, OR, Sept. 20, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Allergy Diagnostics Market garnered $5.0 billion in 2021, and is estimated to generate $16.7 billion by 2031, manifesting a CAGR of 13.2% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for the sustainable growth and gaining competitive edge in the market.

Download Report (390 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/860

Report coverage & details:

Report CoverageDetails
Forecast Period2022­–2031
Base Year2021
Market Size in 2021$5.0 billion
Market Size in 2031$16.7 billion
CAGR13.2%
No. of Pages in Report390
Segments coveredTest Type, Product & Service, Allergen, and End User, and Region.
DriversExposure to allergens
Occupational exposure
Exposure to indoor and outdoor air pollution
OpportunitiesThe growing incidence of sensitive skin and its propensity for irritation
RestraintsFinancial limitations

Covid-19 Scenario:

  • Due to the outbreak of the COVID-19 pandemic in 2020, there was a little slowdown in the market for allergy diagnostics, as diagnostic tests were being postponed due to lockdown scenarios.
  • However, in 2021, the diagnostic processes resumed. To determine the impact of COVID-19 on allergy diagnostic testing services, several research had been done.
  • According to a survey done in Turkey, allergists preferred telemedicine for treating asthma and rhinitis at a high rate. For more serious allergic conditions, such as anaphylaxis and hereditary angioedema, face-to-face interviews were recommended.
  • Other nations such as Italy and the U.S. also showed a similar tendency. Australia reduced the number of outpatient clinic face-to-face consultations for urgent patients with rheumatological disorders and switched approximately 80% of outpatient visits to telemedicine.
  • The expansion of the market was also constrained by this restriction and a decrease in different diagnostic and treatment services.

Specific Requirement? Ask to Our Industry Expert:
https://www.alliedmarketresearch.com/connect-to-analyst/860

The research provides a detailed segmentation of the global allergy diagnostics market based on test type, product & service, allergen, and end user, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.

Based on test type, the in vivo segment held the highest share in 2021, accounting for more than half of the global allergy diagnostics market, and is expected to continue its leadership status during the forecast period. However, the in vitro segment is expected to register the highest CAGR of 13.5% from 2022 to 2031.

Based on product & service, the consumables segment accounted for the highest share in 2021, contributing to around half of the global allergy diagnostics market, and is expected to maintain its lead in terms of revenue during the forecast period. Moreover, the same segment is expected to manifest the highest CAGR of 13.6% from 2022 to 2031.

Based on end user, the diagnostic laboratories segment accounted for the highest share in 2021, holding nearly half of the global allergy diagnostics market, and is expected to continue its leadership status during the forecast period. Moreover, the same segment is estimated to grow at the highest CAGR of 13.7% during the forecast period.

Purchase Inquire:
https://www.alliedmarketresearch.com/purchase-enquiry/860

Based on region, North America held the largest share in 2021, contributing to around one-third of the total allergy diagnostics market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 14.2% during the forecast period. The research also analyzes regions including Europe and LAMEA.

Leading market players of the global allergy diagnostics market analyzed in the research include Alerchek Inc., Danaher Corp, Hitachi chemical Diagnostic Inc., HOB Biotech Group Co. Ltd., Hycor Biomedical Inc., Lincoln Diagnostics Inc., Omega Diagnostic Llc, Siemens Healthcare Diagnostics, Inc., Stallergenes SA, Thermo Fisher Scientific Inc., Thermo Fisher Scientific Inc., Danaher, Omega Diagnostics Group PLC, Eurofins Scientific, bioMérieux SA, HollisterStier Allergy, Minaris Medical America, Inc., ACON Laboratories, Inc., Lincoln Diagnostics, Inc., Neogen Corporation.

The report provides a detailed analysis of these key players of the global allergy diagnostics market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Trending Reports in Healthcare Industry (Book Now with 10% Discount + Covid-19 scenario):

Oncology-Cancer Drugs Market By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), and Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Other Cancers): Opportunity Analysis and Industry Forecast, 2021-2030

Point of Care Diagnostics Market by Product (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy And Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs Abuse Testing Kits, Others), by Mode Of Prescription (Prescription Based Devices, Otc Based Devices), by End User (Professional Diagnostic Centers, Research Laboratories, Home Care, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

3D Printing in Healthcare Market by Component (System, Materials, and Services), Technology [Droplet Deposition, Photopolymerization, Laser Beam Melting, Electronic Beam Melting (EBM), Laminated Object Manufacturing, and Others], Application (External Wearable Devices, Clinical Study Devices, Implants, and Tissue Engineering), and End User (Medical & Surgical Centers, Pharmaceutical & Biotechnology Companies, and Academic Institutions): Global Opportunity Analysis and Industry Forecast, 2021-2030

Vaccines Market by Technology Type (Recombinant & Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, and Other Vaccines), Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, & Rubella {MMR}, Diphtheria, Pertussis, & Tetanus {DPT}, Polio, Hepatitis, and Other Indications), and End User (Pediatric, Adults, and Travelers): Global Opportunity Analysis and Industry Forecast, 2021--2031

Next Generation Sequencing Market by Product (Consumables, Platforms, Services and Nerve Blockers), Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Agriculture and Animal Research, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, and Other Technologies), and End User (Academic and Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Other End Users): Global Opportunity Analysis and Industry Forecast, 2021--2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

 

Contact Data